Enveric Biosciences (ENVB) Competitors $1.10 -0.01 (-0.90%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$1.08 -0.03 (-2.27%) As of 08/15/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENVB vs. FLGC, GOVX, PHIO, PHXM, LGVN, SONN, HOOK, BCDA, PRTG, and IBIOShould you be buying Enveric Biosciences stock or one of its competitors? The main competitors of Enveric Biosciences include Flora Growth (FLGC), GeoVax Labs (GOVX), Phio Pharmaceuticals (PHIO), PHAXIAM Therapeutics (PHXM), Longeveron (LGVN), Sonnet BioTherapeutics (SONN), HOOKIPA Pharma (HOOK), BioCardia (BCDA), Portage Biotech (PRTG), and iBio (IBIO). These companies are all part of the "pharmaceutical products" industry. Enveric Biosciences vs. Its Competitors Flora Growth GeoVax Labs Phio Pharmaceuticals PHAXIAM Therapeutics Longeveron Sonnet BioTherapeutics HOOKIPA Pharma BioCardia Portage Biotech iBio Flora Growth (NASDAQ:FLGC) and Enveric Biosciences (NASDAQ:ENVB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability. Do analysts rate FLGC or ENVB? Flora Growth presently has a consensus target price of $93.00, suggesting a potential upside of 293.53%. Enveric Biosciences has a consensus target price of $10.00, suggesting a potential upside of 809.09%. Given Enveric Biosciences' higher possible upside, analysts clearly believe Enveric Biosciences is more favorable than Flora Growth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Enveric Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, FLGC or ENVB? Enveric Biosciences has lower revenue, but higher earnings than Flora Growth. Flora Growth is trading at a lower price-to-earnings ratio than Enveric Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlora Growth$59.51M0.23-$15.91M-$34.38-0.69Enveric BiosciencesN/AN/A-$9.57M-$38.38-0.03 Which has more volatility and risk, FLGC or ENVB? Flora Growth has a beta of 1.97, meaning that its stock price is 97% more volatile than the S&P 500. Comparatively, Enveric Biosciences has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500. Do institutionals & insiders believe in FLGC or ENVB? 36.0% of Flora Growth shares are held by institutional investors. Comparatively, 13.8% of Enveric Biosciences shares are held by institutional investors. 12.6% of Flora Growth shares are held by company insiders. Comparatively, 1.1% of Enveric Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor FLGC or ENVB? In the previous week, Flora Growth had 1 more articles in the media than Enveric Biosciences. MarketBeat recorded 4 mentions for Flora Growth and 3 mentions for Enveric Biosciences. Enveric Biosciences' average media sentiment score of 2.44 beat Flora Growth's score of 1.15 indicating that Enveric Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Flora Growth 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Enveric Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is FLGC or ENVB more profitable? Enveric Biosciences has a net margin of 0.00% compared to Flora Growth's net margin of -24.86%. Flora Growth's return on equity of -261.57% beat Enveric Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Flora Growth-24.86% -261.57% -48.06% Enveric Biosciences N/A -315.25%-229.90% SummaryFlora Growth beats Enveric Biosciences on 9 of the 14 factors compared between the two stocks. Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ENVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENVB vs. The Competition Export to ExcelMetricEnveric BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.74M$3.10B$5.67B$9.82BDividend YieldN/A2.23%3.79%4.07%P/E Ratio-0.0320.7630.8025.13Price / SalesN/A364.18466.77115.19Price / CashN/A42.3037.4059.05Price / Book0.478.659.096.18Net Income-$9.57M-$54.65M$3.26B$265.11M7 Day Performance-0.90%6.56%7.31%4.20%1 Month Performance-12.70%7.53%5.43%1.99%1 Year Performance-85.06%13.69%30.59%23.75% Enveric Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENVBEnveric Biosciences2.8365 of 5 stars$1.10-0.9%$10.00+809.1%-84.8%$2.74MN/A-0.0320News CoveragePositive NewsEarnings ReportUpcoming EarningsFLGCFlora Growth3.3242 of 5 stars$20.60+9.7%$93.00+351.5%-34.1%$10.84M$59.51M-0.60280Positive NewsShort Interest ↓High Trading VolumeGOVXGeoVax Labs1.8494 of 5 stars$0.68+0.1%$8.88+1,205.5%-77.3%$10.81M$3.95M-0.3410Short Interest ↑PHIOPhio Pharmaceuticals2.5748 of 5 stars$2.13-5.3%$14.00+557.3%-15.5%$10.80MN/A-0.3310News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Gap DownPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58MN/A0.0049LGVNLongeveron3.6952 of 5 stars$0.70+2.6%$8.67+1,146.5%-69.1%$10.29M$2.39M-0.1120News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumeSONNSonnet BioTherapeutics2.9174 of 5 stars$3.07-4.7%$20.00+551.5%-45.4%$10.19M$20K0.0010Earnings ReportAnalyst UpgradeGap DownHOOKHOOKIPA Pharma3.4703 of 5 stars$0.82-6.8%$4.50+448.4%-83.0%$10.00M$9.35M-0.14160Short Interest ↓High Trading VolumeBCDABioCardia3.685 of 5 stars$1.68-6.1%$25.00+1,388.1%-33.8%$9.85M$60K-0.7240Earnings ReportShort Interest ↓PRTGPortage Biotech1.367 of 5 stars$8.85-4.8%N/A+148.0%$9.75MN/A-0.216News CoverageShort Interest ↓IBIOiBio1.1947 of 5 stars$0.59-1.3%$5.00+752.8%-59.9%$9.69M$375K0.00100 Related Companies and Tools Related Companies FLGC Alternatives GOVX Alternatives PHIO Alternatives PHXM Alternatives LGVN Alternatives SONN Alternatives HOOK Alternatives BCDA Alternatives PRTG Alternatives IBIO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ENVB) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access